Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(10%)
Results Posted
60%(3 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_4
1
10%
Ph phase_2
1
10%
Ph phase_3
1
10%
Ph not_applicable
6
60%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(5)
Terminated(2)
Other(2)

Detailed Status

Completed5
unknown2
Withdrawn1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (11.1%)
Phase 31 (11.1%)
Phase 41 (11.1%)
N/A6 (66.7%)

Trials by Status

completed550%
unknown220%
withdrawn110%
recruiting110%
terminated110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10